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ABSTRAK 
TAJUK 
Faktor yang mempengaruhi kelewatan memulakan rawatan di kalangan pesakit 
tuberculosis (TB) berjangkit. 
PENGENALAN 
TB masih merupakan penyakit yang memberi cabaran besar kepada kesihatan komuniti di 
dunia dan khasnya di Malaysia. Kelambatan memulakan rawatan dapat meningkatkan 
mobiditi penyakit, kematian dan transmisi penyakit TB. Kajian ini bertujuan untuk 
mengetahui prevalen pelbagai jenis kelewatan (kelewatan pesakit, kelewatan perkhidmatan 
kesihatan, kelewatan mendiagnosa, kelewatan dalam inisiasi rawatan dan keseluruhan 
kelewatan dalam memulakan rawatan TB) dan faktor-faktor yang mempengaruhi 
kelewatan pesakit dan kelewatan perkhidmatan kesihatan. 
KAEDAH 
Kajian hirisan lintang telah dijalankan dari bulan Oktober 2004 hingga ke bulan Jun 2005 
ke atas 178 orang pesakit TB berjangkit di empat daerah di Kelantan (Kota Bharu, Tumpat, 
Bachok dan Pasir Mas). Semua pesakit yang memenuhi ciri-ciri kajian dan memberikan 
persetujuan ditemuramah disebabkan kekurangan jumlah pesakit untuk memenuhi 
keperluan bilangan sampel. Borang kaji selidik digunakan untuk menemuramah pesakit 
manakala maklumat keputusan makmal diperolehi daripada rekod pesakit. 
XIV 
KEPUTUSAN 
Median dan 'interquartile range' kelewatan pesakit, kelewatan perkhidmatan kesihatan, 
kelewatan mendiagnosa, kelewatan inisiasi dan keseluruhan kelewatan rawatan didalam 
hari masing-masing adalah 30.0(76.00), 7.0(14.50), 3.0(4.00), 3.0(4.00) and 64.0(90.25). 
Prevalen dan 95%CI bagi kelewatan yang melebihi had pula; kelewatan pesakit, kelewatan 
perkhidmatan kesihatan, kelewatan mendiagnosa, kelewatan inisiasi dan keseluruhan 
kelewatan rawatan masing-masing adalah 46.6%(39.3, 53.3), 45.5%(38.2, 52.8), 
48.3%(41.0,55.6), 37.6%(30.5,44.8), 61.8% (54.7,68.9). Analisis melalui 'multiple 
logistic regression' mendapati faktor yang mempengaruhi kelewatan pesakit melebihi had 
adalah faktor umur (OR: 3.88; 95%CI: 1.35, 11.18; p= 0.0 12), jarak rumah pesakit ke 
fasiliti kerajaan pertama dilawati (OR: 3.98; 95%CI: 1.56, 1 0.15; p= 0.004), melawati 
pengamal perubatan tradisional (OR: 10.51; 95%CI, 1.80, 55 .39; p=0.006), melawati 
sektor perubatan swasta (OR: 0.24, 95%CI: 0.09, 0.60; p= 0.002) dan pengaruh stigma 
(OR: 4.81; 95%CI: 1.59, 14.60; p=0.006). Faktor-faktor yang didapati signifikan 
berkaitan dengan kelewatan perkhidmatan kesihatan melebihi had pula adalah keputusan 
awal sapuan kahak yang negative (OR: 14.48; 95%CI: 2.30, 91.34; p=0.004), peningkatan 
jumlah lawatan ke fasiliti kerajaan (OR: 4.99 95%CI: 2.76, 9.03; p= <0.001) dan jenis 
perkhidmatan kerajaan yang dilawati (OR: 5.78; 95%CI: 1.58, 21.11; p= 0.008). 
KESIMPULAN 
Kaj ian ini mendapati bahawa terdapat kelewatan di dalam mengesan kes-kes TB di 
Kelantan. Meningkatkan kesedaran melalui kempen pengajaran kesihatan dan promosi 
kesihatan berkenaan dengan gejala-gejala penyakit TB, kebolehsembuhannya dan 
kesediaadaan fasiliti-fasiliti kerajaan dalam menangani penyakit TB mungkin mampu 
XV 
memendekkan kelewatan pesakit mendapatkan rawatan. Kakitangan-kakitangan kerajaan 
dan swasta perlu disedarkan tentang kepentingan awal membuat diagnosa dan memulakan 
rawatan. Pengamal Kesihatan traditional dan komplementari perlu bekerjasama dan 
berintergrasi dengan sektor kesihatan swasta dan kerajaan dalam menyumbang kepada 
sistem kesihatan negara ini. 
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ABSTRACT 
TOPIC 
Factors influencing delayed treatment among smear positive pulmonary tuberculosis. 
INTRODUCTION 
TB remains a great challenge to public health in Malaysia and worldwide. Delay in 
treatment commencement can result in significant increase morbidity, mortality and 
transmission. Hence this study is aimed to determine the prevalence of various delays 
(patient, health service, diagnosis, initiation and total delay) and to identify the factors 
influencing the patient delay and health service delay. 
METHOD 
A crossectional study was done from October 2004 to June 2005 among 178 smear 
positive pulmonary TB patients in four districts in Kelantan (Kota Bharu, Tumpat, Bachok 
and Pasir Mas). All patients who fulfilled the inclusion and exclusion criteria and gave 
consent were recruited due to limited number of patients. Interviewer guided questionnaire 
was administered and medical record was reviewed to gather patient's information. 
RESULT 
The median and inter-quartile range of patient delay, health service delay, diagnosis delay, 
initiation delay and total treatment delay in days were 30.0(76.00), 7.0(14.50), 3.0(4.00), 
3.0(4.00) and 64.0(90.25) respectively. Furthermore, the prevalence and 95%CI of 
unacceptable delays; patient delay, health service delay, diagnosis delay, initiation delay 
and total treatment delay were 46.6%(39.3, 53.3), 45.5%(38.2, 52.8), 48.3%(41.0,55.6), 
37.6%(30.5,44.8), 61.8% (54.7,68.9) respectively. In multiple logistic regression analysis, 
the significant factors associated with unacceptable patient delay were age (OR: 3.88; 
XVll 
95%CI: 1.35, 11.18; p= 0.0 12), distance from home to first health facilities attended (OR: 
3.98; 95%CI: 1.56, 1 0.15; p= 0.004), attending the T/CM practitioners (OR: 10.51; 95%CI, 
1.80, 55.39; p=0.006), attending the private practitioners (OR: 0.24, 95%CI: 0.09, 0.60; 
p= 0.002) and stigma (OR: 4.81; 95%CI: 1.59, 14.60; p=0.006). On the other hand, the 
significant factors associated with unacceptable health service delay were negative results 
of initial sputum smear (OR: 14.48; 95%CI: 2.30, 91.34; p=0.004), number of visits to 
health facilities (OR: 4.99 95%CI: 2.76, 9.03; p= <0.001) and types of first health care 
facilities attended (OR: 5. 78; 95%CI: 1.58, 21.11; p= 0.008) 
CONCLUSION 
This study showed that there was a substantial delay in case finding in Kelantan. Raising 
public awareness about symptoms of TB, curability and benefit of utilizing available 
governmental health facilities through health education campaign might shorten the patient 
delay. Health care personnel in both private and government sectors should be reminded 
on the important of early diagnosis and prompt treatment of TB. Traditional and 
complementary practitioners should be well-cooperated in contributing to Malaysian health 
care system by interacting with both private and governmental health sectors. 
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1.1 TB Burden 
1.1.1 Globally 
CHAPTER ONE 
INTRODUCTION 
It has been estimated that approximately one-third of the world's population is infected 
with Mycobacterium tuberculosis. More than eight million people developed active TB 
every year, and about 1.8 million die of the disease (Dye eta/., 1999). 
The trend of TB is increasing globally. The total number of new TB cases and its 
incidence rate per capita increased at a rate of 1.8% and 0.4% per year between 1997 and 
2000, respectively. In 2000 there were estimated 8.3 million or 137 per 100,000 
populations of new TB cases globally. Of these 3.7 million (44%) or 61 per 100,000 
populations were infectious pulmonary cases and 5.4 million (65%) were in adults aged 15 
to 49 years. 11% of all new TB cases in adults occurred in persons infected with HIV 
(Corbett et a/., 2003). The 22 high burden countries (incidence rate more than 100, 000 
populations) account for approximately 80% of the estimated number of new TB cases (all 
forms) arising worldwide each year. These countries are; India, China, Indonesia, Nigeria, 
Bangladesh, Pakistan, Ethiopia, South Africa, Philippines, Kenya, DR Congo, Russian 
federation, Vietnam, UR Tanzania, Brazil, Uganda, Thailand, Mozambique, Zimbabwe, 
Myanmar, Afghanistan, and Cambodia (WHO, 2005). 
The WHO African Region (essentially sub-Saharan Africa) had the highest annual 
incidence (290 per I 00 000 population), while the South-East Asian Region had the largest 
number of cases (3.0 million). Half of the new cases were in the top five countries, all in 
Asia and IS highest incidence countries, I3 were in Africa. It is estimated that the 
prevalence was twice the incidence in 2000 (Corbett et al., 2003). Schulzer et al. (I992) 
suggested that there would be a dramatic increase in the number of cases of TB due to HIV 
infection in sub-Saharan Africa. 
TB is one of the ten leading causes of death worldwide (Murray and Lopez, I997) and the 
second cause of death among communicable diseases (Frieden et al., 2003). I.84 million 
people died from TB in 2000, of which I2% was attributable to HIV and the proportion 
was much greater in the WHO African region. The death rates varied dramatically in high 
burden countries, from nine per 100,000 populations in Brazil to 139 per I 00,000 
populations in South Africa. The case fatality rates in these two countries were I3% and 
27% respectively. TB was the cause of 11% of all adult AIDS deaths. (Corbett et al., 
2003). The death rates among HIV -positive patients are much higher during the time they 
are being treated for TB than patient without HIV (Raviglione et al., I997). 
TB remains the public health problem not only in the developing countries but also in 
developed and industrialized countries. In Australia, Hong Kong, China, Japan, Malaysia 
and Singapore, the number of cases has not decreased for several years (WHO, 2002a). 
The resurgence of TB has been not only attributed by HIV infection but also with the 
increasing poverty (Druker et al., I994), increasing immigration (Cantwell et al. 1994), 
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drug resistance (Frieden eta/., 1993), dismantling of control programs, and poor adherence 
to treatment (Brudney and Dobkin, 1991 ). 
TB kills more people than any other single infectious agent and death from TB comprises 
26% of all avoidable deaths in developing countries. More than 90% of global TB cases 
and death occur in the developing world, where 75% are in the most economically 
productive age group ( 15 - 54 years) (Ahlburg, 2000). 
1.1.2 Burden of TB in Western Pacific Region 
There are an estimated two million cases of all types of TB in the Western Pacific Region; 
of these about 850,000 are infectious smear positive cases. However, less than half of 
infectious cases are actually detected. This region is home to four of the 22 high burden 
countries in the world. These four countries are Cambodia, China, the Philippines and 
Vietnam which account for one quarter of the global TB burden. TB detection rate is low 
in this region which was at 41% of estimated incidence (WHO, 2002a). 
The seven high TB burden countries in the regton which account for 94% of TB 
prevalence in this region are Cambodia, China, the Lao People's Democratic Republic, 
Mongolia, Papua New Guinea, the Philippines and Vietnam. Nearly half of the cases in 
these countries are believed to be infectious, but the detection rate, at 44% is lower than the 
regional average of 45%. (WHO, 2002a). In 2003, among the countries mentioned only 
Mongolia and Vietnam reached the 70% case detection rate. (WHO, 2003a) 
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1.1.3 Burden ofTB in Malaysia 
Malaysia is one of the countries in the Western Pacific Region with intermediate burden of 
TB (incidence rate between 25 to I 00 per I 00, 000 population). This disease is still a great 
challenge for public health in this country. It is an important cause of mortality amongst 
the infectious disease. It showed an increased trend by 3.5 per I 00,000 populations since 
I990 to 2000. The incidence rate per I 00,000 populations in 2002 for all TB type and 
infectious smear positive cases were 58.7 and 32.4, respectively (MOH 2000a; MOH 
2002c). 
With regard to Kelantan the incidence rate per 1 00, 000 populations for all type and 
infectious smear positive were 68.1 and 46.2, respectively in 2002, which also showed an 
increasing trend from 65.3 and 42.0, respectively in 2000 (MOH, 2000a). In 2000, the 
number of reported deaths due to TB was 942 out of 15, 057 giving a case fatality rate of 
6.3%. In 2002, there was an increase in the number of reported deaths due to TB, giving a 
case fatality rate of 7.2 %. (MOH 2000a; MOH 2002c). The five highest smear positive 
PTB incidence districts in Kelantan for year 2002 were Tumpat, Bachok, Pasir Puteh, Kota 
Bharu and Tanah Merah. On the other hand, the five highest number of sputum smear 
positive PTB cases by districts in Kelantan were in Kota Bharu, Tumpat, Pasir Mas, 
Bachok and Pasir Puteh (Kelantan State Health Department, 2002). 
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1.2 Introduction to study area 
Kelantan is one of the 13 states in Malaysia. It is located at northeast of Peninsular 
Malaysia in a land area of about 14,922-sq.km and 1 ,522, 200 population. Malay ethnicity 
is the majority, constitutes 94.1% of population followed by 4.6% Chinese, 0.5% Indian 
and 0.8% other ethnicities. The state is devided into ten administrative districts i.e Kota 
Bharu, Pasir Mas, Tumpat, Pasir Puteh, Bachock, Kuala Krai, Machang, Tanah Merah, Jeli 
and Gua Musang (Kelantan State Health department, 2003). 
About 80.0% of the population live in the north of the state that covers 20% of total land 
area. Kota Bharu , the state capital is rapidly growing town being the focal point for 
Kelantan' s administration and business activities (Kelantan State Health department, 
2003). 
There are ten district health offices, 59 health clinics, four maternity and child clinics, 203 
community clinics and 62 dental clinics. In addition, there are 207 private clinics three 
private hospitals, 68 operating pharmacy and 30 private dental clinics in Kelantan. All the 
private hospitals are situated at Kota Bharu, the state capital city (Kelantan State Health 
department, 2003). 
This study was conducted in four districts of Kelantan namely Kota Bharu, Tumpat, 
Bachok and Pasir Mas. All the other three districts surround the Kota Bharu district. 
5 
These four districts were situated at northern part of Kelantan together with Pasir Puteh, 
Machang and Tanah Merah. The four districts chosen in this study have the highest 
number of sputum smear positive PTB cases as mention earlier. Figure 1 shows the 
Kelantan Map highlighting the four districts under study (Kelantan State Health 
department, 2003). 
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Figure I : Kelantan state with ten administrative districts. The dot square is 
showing the four districts under study. 
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1.3 Justification of the study 
In 1993, the World Healh Organization declared a state of global emergency for TB, due to 
steady increase of the disease worldwide (WHO, 1994). In Malaysia TB remains a major 
public health problem. Particular to Kelantan there is an increasing trend for all types of 
TB and smear positive PTB. Case finding is the important element of TB control so, it is 
imperative to explore more about the delay in starting treatment for TB. 
There were only two local studies regarding delay treatment done. Both of them were 
conducted at town area and hospital based. One was done at Penang hospital (Hooi, 1994) 
and the other one was conducted at University Malaya Teaching hospital (Liam and Tang, 
1997). 
1.4 Rationale of the study 
The main strategy of tuberculosis control in developing countries is to improve the cure 
rate by treating as early as possible the largest number of diagnosed TB cases, and 
subsequently to improve case finding; that is, to diagnose cases as quickly as possible and 
as many as possible (Kochi, 1991 ). 
Delay in diagnosis is also the main factor for fatality in tuberculosis patients. It was 
reported in a Bolivian study that the cause of death of TB patients was due to delay in 
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diagnosis which contributed to 38.9% of the patients (Olle Goig, 2000). The matn 
contributer to the tuberculosis fatalities after reviewing autopsy on TB death patients in 
Yugoslavian hospital is the late detection of tuberculosis (Ellis et al., 1983). 
The problem of delayed diagnosis of tuberculosis in patients with HIV infection has 
recently been emphasized. Forty-five percent of those whose diagnosis was delayed died 
of tuberculosis as compared with 19 percent of those who were diagnosed earlier. The 
cause of delayed diagnosis is not due to atypical presentations of tuberculosis but to error 
of manangement (Barnes, et al., 1991 ). 
Tuberculosis from ongoing transmission of M tuberculosis will continue to develop unless 
patients are diagnosed early and contacts are more completely identified. Study done in 
Contra Costa country, California with the annual rate 12.5 cases/100 000 population found 
that 53% developed tuberculosis because of unidentified as contact, 27% developed 
tuberculosis because of delayed diagnosis of their sources, 18% associated with treatment 
of the contact and I% delayed being elicited as contact (P.Chin et al., 2000) 
In view of this and limited information about the delayed treatment it is essential in 
conducting a study to determine the delay in treatment and the factors influencing on it. 
Despite a control programme launched in 1961, there was no single study done in east 
coast of Malaysia to assess the delay treatment of TB. Hence, conducting this study may 
provide the important information on the case finding, clinical management and control of 
TB in Malaysia. 
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CHAPTER 
TWO 
CHAPTER TWO 
OBJECTIVE, RESEARCH QUESTIONS AND HYPOTHESIS 
2.1 General objective 
I. To determine the prevalence of delays in TB treatment and factors influencing on 
it. 
2.2 Specific objective 
I. To determine the prevalence of patient delay, health service delay, diagnosis delay, 
treatment initiation delay and total treatment delay. 
2. To identify the factors associated with the unacceptable patient delay and 
unacceptable health service delay. 
10 
2.3 Research questions. 
I. What is the prevalence of various unacceptable delays (patient delay, health service 
delay, diagnosis delay, initiation delay and total treatment delay)? 
2. Is there an association between unacceptable patient delay and socio demographic 
parameters, patient health conditions and patient's preferences? 
3. Is there an association between unacceptable health service delay and socio 
demographic parameters, patient health conditions and health service factors? 
2.4 Hyphothesis 
I. There is an association between unacceptable patient delay and socio demographic 
parameters, patient health conditions and patient's preferences. 
2. There is an association between unacceptable health servtce delay and socio-
demographic parameters, patient's health conditions and health service factors. 
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2.5 Definitions of operational terms 
I. Definition of operational terms about delays and the acceptable period for each of 
them were based on literatures and considering the local burden of TB and the 
health care system in this country. There are no national or internationally accepted 
standard regarding criteria upon which to define an 'acceptable' period for delay. 
In previous studies, panel of experts have agreed on an acceptable period for total 
treatment delay (duration from the onset of symptoms to the treatment 
commencement) of 30 days (Perkis et a/., 1996) or 60 days (Asch et a/., 1998). 
When the total treatment delay is broken into patient delay and health service delay, 
most studies agreed with 30 days as the 'acceptable' period for patient delay 
(Rajeswari et a/., 2002; Demissie et a/., 2002; Odusanya et a/., 2004) and 15 days 
for health service delay (Demissie et a/., 2002; Odusanya et a/., 2004). The 
acceptable period for diagnosis delay and initiation delay was defined as one week 
(Rajeswari eta/., 2002) and three days (Perkis eta/., 1996) respectively. However, 
in this study, in view of the implementation of National Tuberculosis Information 
System (TBIS) throughout Malaysia in 2003 (Kelantan State Health Department, 
2003) and measurement of the health service delay started from the initial 
consultation at government health facilities researchers concluded to define the 
'acceptable period' for health service delay as seven days (it was not six days 
because to take in consideration the working day in practical). Based on the 
definition mentioned above below are the definitions of the delays in detail 
determine for this study: 
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1.1. Patient delay 
Duration from onset of symptoms to initial consultation at government 
health facilities. 
1.2. Health service delay 
Duration from initial consultation at government health facilities to 
commencement of treatment. This duration is the summation of diagnosis 
and initiation delay. 
1.3. Diagnosis delay 
Duration from initial consultation at government health facilities to smear 
positivity. 
1.4. Initiation delay 
Duration from smear positivity to commencement of treatment. 
1.5. Total treatment delay 
Duration from onset of symptoms to treatment commencement. This delay 
is the summation of patient delay and health service delay. 
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1.6. Unacceptable delay : 
- Unacceptable patient delay : patient delay more than 30 days 
- Unacceptable health service delay : health service delay more than seven 
days. 
- Unacceptable diagnosis delay : diagnosis delay more than three days 
- Unacceptable initiation delay : initiation delay more than three days 
- Unacceptable total treatment delay: total treatment delay more than 37 
days. 
2. Sputum smear-positive pulmonary tuberculosis 
a) Tuberculosis in a patient with at least two initial sputum smear examinations 
(direct smear microscopy) positive for acid fast bacilli (AFB) 
b) Tuberculosis in a patient with one sputum smear examination positive for 
AFB and radiographic abnormalities consistent with active pulmonary TB as 
determined by treating doctor 
c) Tuberculosis in a patient with at least one sputum smear examination positive 
for AFB and sputum culture positive for M tuberculosis 
( MOH, 2002a) 
3. Government health facilities 
Government health clinics or government hospitals including the teaching hospital, 
excluding the community clinics. 
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4. Symptoms 
symptoms were defined as one or more of the following occuring in the previous 
two years and lasting two weeks or more axcept for haemoptysis, if present it was 
considered significant: cough, pleuritic chest pain, fever, loss of weight, loss of 
appetite, and night sweat before they attended the government health facilities for 
seeking treatment. 
(Asch et al., 1998) 
5. Eligible Household contacts 
Household members of an index patients who had been living in the same house as 
index patients for at least four weeks previously. (Klausner et al,. 1993) 
6. Income 
Monthly per capita income in Malaysian ringgit 
7. · Home distance to the first health facility attended 
Distance in kilometers 
8. HIV-infected case 
Patients with reactive ELISA test for HIV -1 and HIV -2, confirmed by particle 
agglutination (PA) test. 
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9. Treatment centres one (TC 1) 
The TC I were chest clinics and certain health clinics which were responsible for 
diagnosis, initiation and continuation of anti-TB treatment. 
(MOH, 2002d) 
I 0. Treatment centres two (TC2) 
The 'TC2' was the term used for the centers which were responsible for the 
treatment continuation only. TC2 can be the health clinics, community clinics or 
chest clinics. 
(MOH, 2002d) 
11. Nearest health clinic 
A government health facility, which was located nearest to the respondent's living 
quartes, with distance measured in kilometers, and not in terms of difficulty of 
physical access. 
I2. Over-the-counter (OTC) drug 
Available without a prescription. OTC drugs are available without a prescription, 
simply "over the counter." OTC drugs are in contrast to prescription drugs that 
require a doctor's order. (Anonymous) 
16 
13. Traditional medicine 
Traditional medicine is the sum total knowledge, skills and practices on holistic 
healthcare, which is recognized and accepted by the community for its role in the 
maintenance of health and the treatment of diseases. Traditional medicine is based 
on theory, beliefs and experiences that are indigenous to different cultures, and that 
is developed and handed down from generation to generation. 
(MOH, 2001) 
14. Complementary medicine 
Refer to wide range of health interventions originating from different cultures 
across thousands of years of history. 
(MOH, 2001) 
15. Covariate pattern 
A single set of values for the covariates in a model. 
(Hosmer and Lemeshow, 2000) 
17 
CHAPTER 
THREE 
3.1 Bacteriology of TB 
CHAPTER THREE 
LITERATURE REVIEW 
Mycobacterium tuberculosis, the causative agent of TB, usually is readily identified by its 
rough, non-pigmented, corded colonies on oleic-acid-albumin agars; a positive niacin test; 
generally weak catalase activity, which is lost completely by heating to 68° C; and a 
positive nitrate reduction test (American Thoracic Society, 1990). 
Those mycobacterium that are obligate pathogens causing human disease (with the 
exception of M leprae) are known as the 'M tuberculosis complex'. This consists of M 
tuberculosis, which makes up the vast bulk of cases, M africanum and M bovis. M 
microti and the bacillus Calmette-Guerin (BCG) vaccine strain, while strictly members of 
TB 'complex', only cause disease under special circumstances (Ormerod, 2003). 
3.2 Pathogenesis of TB 
M tuberculosis enters the body via the respiratory tract through inhalation of respiratory 
droplet nuclei, which are very small in size (l-2J.1m or less). It reaches the alveoli within 
the lungs, where the organism replicates. The larger particle containing the numerous M 
tuberculosis bacilli that can also be generated by the patients are efficiently excluded and 
does not reach alveoli by the physical barriers of nasopharynx and upper respiratory tract 
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(Riley et a/., 1995). The organisms grow slowly for two to 12 weeks, until they reach 1 03 
to 104 in number which is sufficient to elicit a cellular immune response that can be 
detected by tuberculin skin test (Smith and Wiegneshaus, 1989). Once in the alveoli, the 
organisms are taken up by alveolar macrophages and spread throughout the body via 
hematogenous route (Dannenberg, 1994). 
Once the organisms have made their way into the lung, they have four potential fates. (1) 
The initial host response can be completely effective and kill all bacilli; (2) the organism 
can begin to multiply and grow immediately after infection causing the primary TB; (3) 
bacilli may become dormant and never cause disease referred to as latent infection which 
can be detect by tuberculin skin test; (4) latent organisms can eventually begin to grow, 
with resultant clinical disease, known as reactivation TB (Dannenberg, 1994 ). 
Granuloma is the cardinal feature of initial response to TB and its role in host defenses 
against M tuberculosis. In persons with intact cell-mediated immunity, collections of 
activated T cells and macrophages from granulomas limit multiplication and spread of the 
organism (Saunder and Cooper, 2000). Individuals with latent TB infection but not active 
are not infectious and thus cannot transmit the organism. Flynn and Chan (200 1) conclude 
that the host responses is important in controlling the latent infection which may include 
macrophages activation, maintenance of granuloma structure, CD4 T cells, CD8 T cells, 
IFN-y, and TNF-a. Still to be tested are the contribution of other cytokines or chemokines 
to the establishment and control of latent TB infection. 
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3.3 Transmission of Mycobacterium tuberculosis 
TheM tuberculosis is carried on airborne droplet nuclei which are produced when persons 
with PTB cough, sneeze, speak, or sing (American Thoracic Society, 1990). Airborne 
route which transmits TB was suspected by Koch in 1932 to proof tubercle bacilli as the 
cause of TB. Wells at the Harvard school of Public Health in 1934 made a major 
breakthrough in the understanding of airborne transmission ofTB (Cited in Rieder, 1999). 
Fennelly et a/. (2004) presented a novel approach to directly assessing the potential 
infectiousness of patients with PTB. Cough aerosol sampling system was used to culture 
the cough-generated aerosol from 16 smear positive PTB patients. Among the subject only 
33 % was found to be aerosol cultured positive, this suggested that there may be 
considerable variability in the ability to produce potentially infectious aerosols. The size 
distributions suggest that most of the viable particles in these cough-generated aerosols are 
immediately respirable. An editorial by Nardell commented on Fennelly study sampling 
occurs at extremely close proximity to the infectious source where there was little time for 
droplet nuclei to dry and it is unclear whether some of these cultured organisms remain 
infectious in a room very long (Nardell, 2004). 
Patients in whom tubercle bacilli can be detected by direct examination of the sputum 
smear are the main sources of transmission (Shaw and Williams, 1954; Lienhardt, 2003). 
Smear positive persons expectorate I 08 - 1010 bacilli daily (Potterger, 1948), or about 106 
- 107 per ml of sputum (Yeager eta/., 1967). 
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Study by Shaw and Williams (1954) also showed that not only cases of infection but also 
cases of TB disease, are more frequent among contact of sputum positive compare to the 
culture only positive and sputum negative cases. This finding is also similar with to 
Underwood eta/. (2003) study between 1997 to 1999 in East London which found the rate 
of TB disease among contacts were 4.9% of those exposed to sputum positive cases 
compared to 1.9% of those exposed to smear-positive PTB and 0.9% of those exposed to 
non PTB cases. 
The effect of chemotherapy has been shown to reduce the infectivity of TB. These facts 
seem to indicate the very rapid and powerful action by the drugs on infectivity. Brooks et 
a/. (1973) for example studied I 07 subjects living in close contact with 21 patients with 
positive sputum. After a period in hospital of up to 23 days, 19 of these patients, while still 
positive, were sent home (none of the 72 tuberculin-negative in contacts after the 
beginning of treatment showed conversion of their tuberculin tests). 
Gunnels eta/. (1974) studied contacts of 155 patients who were sent home after one month 
of treatment in hospital. These patients were divided into three groups according to 
whether they were negative on culture, positive on culture, or positive both on culture and 
on direct examination at the time of discharge from hospital. No difference was found in 
the frequency of infection in the contacts corresponding to these three groups of patients. 
21 
The effect of chemotherapy on the cough-generated aerosol culture for M tuberculosis by 
Fennelly et a/. (2004) showed that there were rapid decrease in cough-generated aerosol 
culture within the first three weeks of effective treatment of sputum-positive TB patients 
and the decrease rate to be considerably more rapid than the sputum culture and this 
suggested that patients became noninfectious within a few weeks of effective treatment. 
The duration of infectiousness especially among the sputum positive TB is the crucial 
importance for the risk of infectivity. The risk of becoming exposed is greatly enhanced if 
infectiousness is prolonged compared with a short duration of infectiousness. An untreated 
case of infectious TB will remain infectious for longer period of time than a patients 
treated in timely manner (Rieder, 1999). The proportion of household contacts being 
infected were 23% from the time of diagnosis of TB made in index case suggest that 
probably the infection occurred one to two months prior to treatment of the index cases 
(Riley and Moddie, 1974). A Study by Reichler eta/. (1996) in United State showed 32% 
of close contacts of active PTB were positive TST. A Study carried out by Klausner eta/. 
(1993) from April 1989 through February 1990 in Kinshasa, Zaire found that there was 
high percentage of infectivity among household contacts, 60% whose exposed to HIV-
seropositive sputum culture positive index cases and 63% whose exposed to HIV-
seronegative sputum positive index cases at the time the patients being diagnosed 
Several host factors influence transmission. Increasing age is shown to be the risk factors 
to have TB infection. Klausner eta/. (1993) found the prevalence of M 
tuberculous infection increased with increasing age of household contacts. A Study in 
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Gambia by Lienhardt et al. (2003) had similar finding with age and sex interaction by 
which the odds of having TST positive is higher in both sex with increasing age group but 
more in male. 
3.4 Risk factors for disease given that infection has occurred. 
In general, persons who are infected with M tuberculosis have approximately a 1 0% risk 
for developing active TB during their lifetime. Information from the tuberculin-positive 
placebo group in BCG vaccination trials indicated that the incidence of TB is the highest in 
the first few years after infection and rapidly falls off (D 'Arcy Hart and Sutherland, 1977). 
It is a strong factor, with recent infection being ten times more likely to produce a case 
than long standing infection (Rieder, 1999). 
Horsburgh (2004) reviewed prospective cohort studies and published reports between 1949 
to 2003 in United States to determine which patients had the greatest lifetime likelihood of 
reactivation disease. The risk of reactivation decrease for the first nine years after 
conversion and then 1 0% per decade thereafter. The annual risk of reactivation are 
greatest for patients with a skin-test induration > 15 mm and patients with known recent 
conversion. The lifetime risk of TB falls with increasing age at the time of first positive 
skin test. Children less than five years have the highest lifetime risk (I 0% to 12%) and 
adult more than 35 years exhibiting a lifetime risk of less than 5% (Horsburgh, 2004). 
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Many studies show that TB was affecting males compared to females (Haffernan et a/., 
1975; Rieder eta/., 1989; Enarson, Wang and Dirks, 1989). In the United States males are 
twice as likely to have clinical TB and this finding was similar across the two races (White 
and Black). In the urban area in Canada, the TB incidence rates for those born in Canada 
were observed to be higher for men than for women. A striking difference in the 
likelihood of developing extra-PTB was found between male and female patients with TB 
in the study on extraPTB in the United States. All other extrapulmonary forms except 
pleural TB were consistently more likely to develop in female than male. Pleural TB was 
equally likely to develop in male and female (Rieder eta/., 1990). 
The HIV -seropositive patients have an extraordinary high risk of developing clinical TB, 
compared to HIV -seronegative individuals. Selwyn et a/. ( 1989) found that eight of 212 
HIV -infected intravenous drug users developed TB in a two year period of observation, a 
case rate of 8/100 person-years of observation. Of these, seven developed within a subset 
of 49 persons who were known to be tuberculin-positive. Thus, the case rate for persons 
who were dually infected with both HIV and M tuberculosis was 7.9/100 person-years. 
This exceeds the lifetime risk of a person with TB infection who is not HIV -infected. 
A Cohort study by Cowie (I 994) of I, 153 older gold miners with and without silicosis 
found that the relative risk for TB was 2.8 for men with silicosis compared with that in the 
men without silicosis. Conditions like diabetes mellitus haematologic malignancies and 
uraemia or therapies like cancer chemotherapy, that interfere with cell-mediated immunity 
also increase the risk of TB (Cited in Rieder, I 999). 
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